CEO: Daniel Tassé
Employees: 106
IPO: Oct 22, 2014
Prijs
€ 21,06
Verandering
▲ € 0,56
2,73%
Marktkapitalisatie
503,79M
Dagbereik
€ 19,89
€ 21,33
52-Weeksbereik
€ 6,00
€ 26,19
Volume
445.419
50D / 200D Gem.
€ 21,55
€ 15,04
Vorige Slotkoers
€ 20,50
Quick Summary
Belangrijkste Punten
Debt/Equity of 0,13 — conservative balance sheet
Negative free cash flow of -121,18M
PEG of 0,36 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-150,29%
Onder sectorgemiddelde (3,46%)
ROIC-60,32%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,13
Onder sectorgemiddelde (0,23)
Current Ratio3,67
Interest Coverage0,00
Waardering
P/E Ratio
-3,42
Onder sectorgemiddelde (0,22)
Forward P/EN/A
P/B Ratio2,99
EV/EBITDAN/A
Dividend Yield0,00%
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (640 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,4 | 0,2 |
| P/B | 3,0 | 2,9 |
| ROE % | -150,3 | 3,5 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 9,6 |
| D/E | 0,1 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -147,40M |
| ROE | -150,29% | ROA | -63,07% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -121,18M |
| ROIC | -60,32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 3,67 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,42 | Forward P/E | N/A |
| P/B Ratio | 2,99 | P/S Ratio | N/A |
| PEG Ratio | 0,36 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -24,05% | ||
| Market Cap | 503,79M | Enterprise Value | 331,31M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 15,73M | 4,80M | 5,71M |
| Net Income | -147,40M | -113,72M | -72,73M | -96,30M | -97,81M |
| EPS (Diluted) | -5,30 | -5,90 | -3,80 | -6,20 | -8,90 |
| Gross Profit | -17,67M | -6,81M | 15,73M | -15,50M | -3,57M |
| Operating Income | -153,16M | -120,53M | -76,43M | -96,63M | -98,61M |
| EBITDA | -135,49M | -110,99M | -63,27M | -76,68M | -91,16M |
| R&D Expenses | 22,78M | 89,90M | 60,22M | 75,50M | 70,34M |
| SG&A Expenses | 17,24M | 23,81M | 31,94M | 17,56M | 23,83M |
| D&A | 17,67M | 6,81M | 13,16M | 20,30M | 8,38M |
| Interest Expense | 0,0 | 0,0 | 0,0 | 427.000,0 | 690.000,0 |
| Income Tax | -5,16M | -4,08M | 7.000,0 | 70.000,0 | -381.000,0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 233,72M | 65,66M | 182,99M | 246,52M | 146,32M |
| Total Liabilities | 64,95M | 38,27M | 42,80M | 52,07M | 47,29M |
| Shareholders' Equity | 168,77M | 27,39M | 140,19M | 194,45M | 99,03M |
| Total Debt | 21,68M | 7,80M | 6,55M | 4,15M | 10,66M |
| Cash & Equivalents | 194,17M | 32,46M | 141,37M | 209,19M | 77,30M |
| Current Assets | 212,94M | 44,39M | 158,92M | 223,07M | 114,52M |
| Current Liabilities | 58,03M | 31,14M | 37,34M | 29,52M | 31,40M |